August 25, 2016 9:51 PM ET


Company Overview of Agios Pharmaceuticals, Inc.

Key Executives for Agios Pharmaceuticals, Inc.

NameBoard RelationshipsTitleAge
David P. Schenkein M.D.54 RelationshipsChief Executive Officer, President and Director59
Lewis Clayton Cantley Ph.D.69 RelationshipsCo-Founder, Director, Member of Scientific Advisory Board and Member of Science & Technology Committee67
Tak Wah Mak Ph.D., D.Sc.,FRSC154 RelationshipsCo-Founder and Member of Scientific Advisory Board70
Shin-San Su Ph.D.No RelationshipsCo-Founder60
Craig B. Thompson M.D.131 RelationshipsCo-Founder and Chairman of Scientific Advisory Board63
View More Key Executives

Agios Pharmaceuticals, Inc. Board Members*

NameBoard RelationshipsPrimary CompanyAge
Marc Tessier-Lavigne Ph.D. 73 RelationshipsDenali Therapeutics Inc.56
David P. Schenkein M.D. 54 RelationshipsAgios Pharmaceuticals, Inc.59
Lewis Clayton Cantley Ph.D. 69 RelationshipsAgios Pharmaceuticals, Inc.67
Tak Wah Mak Ph.D., D.Sc.,FRSC 154 RelationshipsAgios Pharmaceuticals, Inc.70
Craig B. Thompson M.D. 131 RelationshipsAgios Pharmaceuticals, Inc.63
View All Board Members

Agios Pharmaceuticals, Inc. Executive Committees*

Committee NameChairpersonBoard RelationshipsMembers
Audit Committee M.B.A.Paul J. Clancy21 Relationships3 Executives
Compensation Committee Kaye I. Foster-Cheek39 Relationships2 Executives
Nominating Committee Kaye I. Foster-Cheek39 Relationships3 Executives
Corporate Governance Committee Kaye I. Foster-Cheek39 Relationships3 Executives
Advisory Board M.D.Craig B. Thompson131 Relationships8 Executives
View Committee Details
*Data is at least as current as the most recent Definitive Proxy.

The information and data displayed in this profile are created and managed by Capital IQ, a Standard & Poor's company. does not create or control the content. For inquiries, please contact Capital IQ directly by clicking here.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup


  Industry Range
Not meaningful
Total Short Term Compensation$54.6M
Not meaningful
Total Value of Options$517.5K
Compensation as of Fiscal Year 2015
Agios Pharmaceuticals, Inc. CEO Compensation
Industry Average


OptiBiotix Health plc Announces Executive Changes
August 25, 2016 6:00 AM ET
Pacific Edge Limited Announces Board Changes
August 25, 2016 2:34 AM ET
BeiGene, Ltd. Appoints Amy Peterson as Chief Medical Officer, Immuno-Oncology
August 24, 2016 8:15 PM ET
Franco Valle Assumes as Interim Principal Accounting Officer of Lion Biotechnologies, Inc
August 24, 2016 8:08 PM ET
TxCell SA Appoints Olivier Danos to its Scientific Advisory Board
August 24, 2016 3:45 PM ET

Sponsored Financial Commentaries

Sponsored Links

Request Profile Update

Only a company representative may request an update for the company profile. Documentation will be required.

To contact Agios Pharmaceuticals, Inc., please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at